www.PRSJournal.com 495e Reply: The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Healing after Nipple-Sparing Mastectomy Sir: We would like to thank Dr. Altundag for his comments regarding our recently published study, “The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Healing after NippleSparing Mastectomy.”1 Nipple-sparing mastectomy places increased stress on the breast skin envelope, which can place patients at risk for ischemia-related complications such as mastectomy and nipple-areola complex necrosis, among other complications. Therefore, nipple-sparing mastectomy was initially offered routinely only to very carefully selected patients, usually undergoing mastectomy for prophylactic indications, because of both reconstructive and oncologic concerns. Nevertheless, as experience with nipplesparing mastectomy has grown, oncologic outcomes have been shown to approach those reached with traditional mastectomy techniques, such as skin-sparing mastectomy. Likewise, complication rates with nipplesparing mastectomy have been shown to be acceptably low. As such, nipple-sparing mastectomy is now being Letters
[1]
M. Naughton,et al.
Impact of Neoadjuvant and Adjuvant Chemotherapy on Immediate Tissue Expander Breast Reconstruction
,
2016,
Annals of Surgical Oncology.
[2]
M. Alperovich,et al.
Nipple-Sparing Mastectomy in Patients with Prior Breast Irradiation: Are Patients at Higher Risk for Reconstructive Complications?
,
2014,
Plastic and reconstructive surgery.
[3]
Phoebe E. Freer,et al.
Increasing Eligibility for Nipple-Sparing Mastectomy
,
2013,
Annals of Surgical Oncology.
[4]
J. Frey,et al.
The Effect of Neoadjuvant Chemotherapy Compared to Adjuvant Chemotherapy in Healing after Nipple-Sparing Mastectomy
,
2017,
Plastic and reconstructive surgery.